Skip to Content

Credit risk management during the COVID-19 pandemic

Presented By:
Steve Schick
Date:
Thursday, November 19, 2020
View on-demand

Listen in as our loan review specialists share their experiences helping clients manage their credit risk through the pandemic as part of the Plante Moran 2020 Financial Institutions Symposium, now available on demand.

View of columns of a government capital building.

During this virtual panel discussion, Plante Moran loan review experts discussed the impact of the COVID-19 pandemic on loan administration and credit risk management. The panelists shared observations from their work with various bank clients, including strategies and tactics for positioning your financial institution to weather the pandemic and come out stronger. 

Learning objectives: 

  • Identify current loan administration and credit challenges resulting from the pandemic, the upcoming presidential election, and other market factors.
  • Analyze the impact of those challenges on credit risk and portfolio management.
  • Identify strategies currently being used by financial institutions to manage emerging credit risk.
  • Determine actions your institution should be taking to mitigate these risks.

Moderator: 

  • Steve Schick, partner

Panelists:

  • John Spear, senior manager and loan review specialist
  • Tom Siska, senior manager and loan review specialist
  • Kevin Garcia, senior manager and loan review specialist

This webinar is part of the Plante Moran 2020 Financial Institutions Symposium. Be sure to check out the other sessions on demand here.

Related Thinking

View of columns of a government capital building.
November 17, 2020

2020 Financial Institutions Symposium: Available on demand

Webinar 2 hour watch
Business professional walking on a sidewalk near a glass building
March 18, 2024

Community Reinvestment Act & Section 1071: Adapting to change in 2024

Article 4 min read
People walking in front of a U.S. government building in daytime.
March 4, 2024

State conformity to IRC Section 174 R&D cost capitalization rules can vary

Article 3 min read